Skip to main content

Hamilton Insurance Group, Ltd.

For the period ended Sep 30, 2025. Filed Nov 5, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2025 · Filed Nov 5, 2025

HG$38.82+3.9%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Unaudited Condensed Consolidated Statements of Cash Flows

Nine Months Ended
($ in thousands)September 30,
Operating activities20252024
Net income (loss)$625,476$538,749
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization12,99713,081
Share compensation expense21,14022,264
Net realized (gains) losses on investments(424,142)(382,646)
Change in net unrealized (gains) losses on investments(147,822)(72,205)
Other items(26,695)(11,786)
Change in:
Premiums receivable(240,293)(227,381)
Paid losses recoverable18,559(806)
Deferred acquisition costs(50,275)(49,058)
Prepaid reinsurance(115,104)(65,868)
Unpaid losses and loss adjustment expenses recoverable(132,793)(29,388)
Other assets(8,767)17,111
Reserve for losses and loss adjustment expenses673,586404,763
Unearned premiums321,183280,849
Reinsurance balances payable111,43662,201
Accounts payable and accrued expenses and other(89,561)(24,667)
Net cash provided by (used in) operating activities548,925475,213
Investing activities
Proceeds from redemptions from Two Sigma Funds2,178,0162,129,185
Contributions to Two Sigma Funds(2,258,072)(1,836,664)
Purchases of fixed maturity investments(1,775,109)(1,466,805)
Proceeds from sales, redemptions and maturity of fixed maturity investments1,212,2841,032,664
Purchases of short-term investments(900,482)(1,335,003)
Proceeds from sales of short-term investments1,165,0871,288,278
Change in receivables for investments sold28,8243,340
Change in payables for investments purchased(13,414)106,299
Other(8,513)(16,570)
Net cash provided by (used in) investing activities(371,379)(95,276)
Financing activities
Issuance of common shares1111
Repurchases of common shares(92,341)(123,394)
Contribution of additional paid-in capital(12)386
Term loan, net of issuance costs(311)—
Withdrawal of non-controlling interest(139,939)(112,313)
Net cash provided by (used in) financing activities(232,592)(235,310)
Effect of exchange rate changes on cash and cash equivalents and restricted cash and cash equivalents19,4115,768
Net increase (decrease) in cash and cash equivalents and restricted cash and cash equivalents(35,635)150,395
Cash and cash equivalents and restricted cash and cash equivalents, beginning of period1,100,852900,860
Cash and cash equivalents and restricted cash and cash equivalents, end of period$1,065,217$1,051,255
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.